Use Cases for Artificial Intelligence and Machine Learning in Late-stage Life SciencesWhite paper
We are living through one of the most transformative eras in our lifetime. The rise of working, usable artificial intelligence (AI) coupled with machine learning (ML) is transforming so many things in our day-to-day lives that soon, we will wonder how life before AI was possible. The development of new medications and therapies is one of the areas that is poised to change more dramatically than most, thanks to these new technologies. AI and ML have immense potential in various aspects of life sciences, including clinical trials. In Stage 3 clinical trials involving large-scale testing of a potential drug or treatment, AI and ML can be crucial in optimizing processes, improving efficiency, and enhancing decision-making. This paper will discuss ten of the most transformative use cases in the late-stage drug development pipeline, including Stage III clinical trials, Medical Affairs, Safety, and Regulatory Affairs.
Scientific Publications
Supervised machine learning for microbiomics: Bridging the gap between current and best practices
Toward a responsible future: recommendations for AI-enabled clinical decision support
Explainable AI to identify radiographic features of pulmonary edema
Identifying the capabilities for creating next-generation registries: a guide for data leaders and a case for “registry science”
Structure Seer – a machine learning model for chemical structure elucidation from node labelling of a molecular graph
Perfect prosthetic heart valve: generative design with machine learning, modeling, and optimization
Excess mortality in Ukraine during the course of COVID-19 pandemic in 2020–2021
Use of semi-synthetic data for catheter segmentation improvement
A multi-reference poly-conformational method for in silico design, optimization, and repositioning of pharmaceutical compounds illustrated for selected SARS-CoV-2 ligands
Novel Efficient Multistage Lead Optimization Pipeline Experimentally Validated for DYRK1B Selective Inhibitors
AnFiSA: an Open-Source Computational Platform for the Analysis of Sequencing Data for Rare Genetic Disease
PyVaporation: A Python Package for Studying and Modelling Pervaporation Processes
Automatic Scoring of COVID-19 Severity in X-ray Imaging Based on a Novel Deep Learning Workflow
Indirect supervision applied to COVID-19 and pneumonia classification
Analysis of 329,942 SARS-CoV-2 Records Retrieved from GISAID Database
Quantori is excited to share research findings that are available on Cold Spring Harbor Laboratory's bioRxiv preprint server for biology "Analysis of 329,942 SARS-CoV-2 records retrieved from GISAID database"